@cnbc: Amgen said its experimental #weightloss injection helped patients lose up to 20% of their weight on average after a year, with no plateau, in a critical mid-stage trial. But shares of #Amgen fell on Tuesday, as the results appear to be at the lower end of Wall Street’s lofty expectations for the drug. Read more about what this data means for the company at the #linkinbio or tap the link on screen. #cnbc